**Core Concept**
The concept being tested here is the principle of drug specificity, which refers to the ability of a drug to interact with its intended target molecule without affecting other molecules. This is crucial in minimizing side effects and ensuring the efficacy of the drug.

**Why the Correct Answer is Right**
The correct answer is related to the concept of pharmacokinetics, specifically the drug's plasma protein binding. A drug with high plasma protein binding has a reduced tendency to interact with molecules other than its target. This is because the drug is bound to plasma proteins, such as albumin, and is less available to interact with other molecules. As a result, the risk of side effects is minimized.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because a high lipid solubility of a drug does not necessarily minimize its interactions with molecules other than its target. In fact, lipid-soluble drugs can more easily cross cell membranes and interact with various molecules.
* **Option B:** This option is incorrect because a high water solubility of a drug does not directly affect its interactions with molecules other than its target. While water-soluble drugs may be less likely to cause lipid-based side effects, they can still interact with other molecules.
* **Option C:** This option is incorrect because a high metabolic rate of a drug does not directly minimize its interactions with molecules other than its target. In fact, rapid metabolism can lead to a shorter half-life and increased risk of side effects.

**Clinical Pearl / High-Yield Fact**
A high plasma protein binding of a drug can lead to a reduced clearance and increased risk of toxicity. This is because the bound drug is not available for metabolism and excretion, leading to a prolonged exposure to the drug.

**Correct Answer: C. High metabolic rate**